Collecting and Storing Samples of Blood From Patients With Pancreatic Cancer and Healthy Participants
NCT00898482 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88
Last updated 2015-11-20
Summary
RATIONALE: Collecting and storing samples of blood from patients with cancer and healthy participants to test in the laboratory may help the study of cancer in the future.
PURPOSE: This study is collecting and storing samples of blood from patients with pancreatic cancer and healthy participants.
Conditions
Interventions
- OTHER
-
This is a non-intervention study for all groups.
This is a non-intervention study.
- OTHER
-
study of socioeconomic and demographic variables
Non-intervention study.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
lead OTHER
Principal Investigators
-
Daniel A. Laheru, MD · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eligibility
- Min Age
- 18 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-05-31
- Primary Completion
- 2011-06-30
- Completion
- 2011-06-30
More Related Trials
-
Pancreatic Adenocarcinoma Gene Environment Risk Study
NCT00912717 ·Status: RECRUITING
-
Surgery for Pancreatic Tumors and Collection of Tumor Tissue for Study
NCT00100321 ·Status: TERMINATED
-
Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
NCT02471170 ·Status: ENROLLING_BY_INVITATION
-
Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis
NCT02869802 ·Status: RECRUITING
-
Collection of Circulating Biomarkers in Pancreatic Cancer
NCT05743049 ·Status: RECRUITING
-
Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer
NCT00826982 ·Status: COMPLETED
-
Identification of Biomarkers for Early Detection of Pancreatic Cancer
NCT00897494 ·Status: COMPLETED
-
Biomarkers in Predicting Response to Treatment in Patients Who Have Undergone Surgery for Pancreatic Cancer
NCT00897832 ·Status: COMPLETED
-
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma
NCT03334708 ·Status: RECRUITING
-
Studying Fibroblast Activity in Patients With Localized Pancreatic Cancer Undergoing Surgery
NCT00900016 ·Status: COMPLETED
-
S9924 R115777 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
NCT00005832 ·Status: COMPLETED ·Phase: PHASE2
-
Multicenter Study of Circulating Tumor DNA in Patients With Pancreatic Cancer Using a Personalized Panel
NCT06043921 ·Status: RECRUITING
-
Bio-Repository of High Risk Cohorts for the Early Detection of Pancreas Cancer
NCT03260842 ·Status: RECRUITING
-
Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
NCT00005926 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
NCT05687188 ·Status: RECRUITING
-
Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer
NCT00559598 ·Status: COMPLETED
-
Pancreatic Cancer Serum and DNA Repository
NCT00296114 ·Status: COMPLETED
-
Florida Pancreas Collaborative Next Generation Biobank
NCT03851133 ·Status: ACTIVE_NOT_RECRUITING
-
Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer
NCT07036978 ·Status: NOT_YET_RECRUITING
-
Pancreatic Cancer Collaborative Registry
NCT00661882 ·Status: COMPLETED
-
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
NCT06998940 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Locally Advanced Pancreatic Cancer
NCT01063192 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients
NCT01198522 ·Status: TERMINATED ·Phase: PHASE1
-
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT07271823 ·Status: ACTIVE_NOT_RECRUITING
-
Saracatinib in Treating Patients With Previously Treated Metastatic Pancreatic Cancer
NCT00735917 ·Status: COMPLETED ·Phase: PHASE2